<DOC>
	<DOCNO>NCT00401284</DOCNO>
	<brief_summary>The purpose study determine whether compound know EVT 201 effective treat elderly patient diagnose primary insomnia also moderate daytime sleepiness .</brief_summary>
	<brief_title>Efficacy Study EVT 201 Treatment Elderly Patients With Daytime Sleepiness</brief_title>
	<detailed_description />
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<criteria>Diagnosis primary insomnia accord DSMIV Over last three month least 5 night per week , must normal bedtime 9 pm 1 time bed least 7 hour A history sleepiness , tiredness unintentional napping daytime attribute poor sleep night Able attend Sleep Center five night ( two consecutive night two occasion one night one occasion ) five week period Willing able complete sleep diary questionnaire Clinically significant unstable medical condition may interfere sleep Major psychiatric disorder ( insomnia ) depression , schizophrenia , bipolar disorder History myocardial infarction , cardiac failure clinically significant dysrhythmias previous 2 year clinically significant ECG abnormality screen History substance abuse Disorders interfere drug pharmacokinetics History cancer , except basal cell carcinoma Use hypnotic , anxiolytic , antidepressant , anticonvulsant , overthecounter sleep aid , histamine1 receptor antagonist ( except loratadine fexofenadine ) , betaadrenergic blocker ( except atenolol ) , respiratory stimulant decongestant , systemic steroid , narcotic analgesic , compound might impact sleepwake function , medication use treatment Parkinson 's disease dopamine agonists Ldopa ( e.g. , Sinemet , Madopar Requip ) Use hypnotic within 2 week precede Screening Period within five halflives medication , whichever longer Consuming ≥ 350 mg per day xanthinecontaining food beverage Smoking ≥ 10 cigarette per day and/or unable refrain smoking without distress discomfort duration visit sleep laboratory ( i.e.≥ 20 hour ) Body mass index &gt; 34 kg/m2 ; Performing night work rotate shift work past month Traveling across &gt; 3 time zone past 2 week Participation another trial investigational product device within previous 30 day Known allergy sensitivity benzodiazepine</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2008</verification_date>
</DOC>